Jubilant Pharmova Ltd.

JUBLPHARMA

Market Cap
₹11,160 Cr.
P/E
294.77

Jubilant Pharmova Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

7 Yes

Positive for this company

1 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
-1.13%
3yr Average
8.09%
5yr Average
10.45%
Net Profit Margin
Latest
-0.97%
3yr Average
6.5%
5yr Average
8.16%
ROCE
Latest
2.85%
3yr Average
8.73%
5yr Average
10.85%
Debt to Equity
Latest
0.63
3yr Average
0.58
5yr Average
0.71
Market Share
62% (as of Mar 18)
Acetic Anhydride - Domestic Market Share
0.06% (as of Jul 22)
Anti - Diabetes - Market Share
0.06% (as of Jul 22)
Cardiovascular - Market Share
0.01% (as of Feb 21)
Neurological - Market Share
0.02% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.03% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
18% (as of Mar 18)
Vitamin B3 - Global Market Share
64% (as of Mar 18)
Vitamin B4 - Domestic Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Contract Research

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Pharmaceuticals

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Capex

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Australia DMF fillings (.)
      Source
    • US DMF Filings (.)
      Source
    • Canada DMF fillings (.)
      Source
    • Japan DMF Filings (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in Canada
      Source
    • Number of ANDA's Approved by Canada
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Jubilant Pharmova Ltd.
    View the discussion on ValuePickr
    Jubilant vs Syngene in CDMO - UnseenValue
    Chemical Sector
    Chemicals Sector - Breakdown and Value Chain - PPFAS
    Chemical Industry - Top Down - Capital Mind
    Battery Chemistry Of EV's - Value Educator
    Indian agrichemical overview - a sectoral perspective - ValuePickr
    Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan
    Understanding the Agri-Inputs Industry - PPFAS
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline